Weber Frank, Teresi Rosemary E, Broelsch Christoph E, Frilling Andrea, Eng Charis
Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, NE-50, Cleveland, Ohio 44195, USA.
J Clin Endocrinol Metab. 2006 Sep;91(9):3584-91. doi: 10.1210/jc.2006-0693. Epub 2006 Jul 5.
Although the pathogenesis of follicular thyroid carcinoma (FTC) and its relation to follicular adenoma (FA) remains unclear, detailed understanding of FTC carcinogenesis would facilitate addressing the scientific and clinical challenges, given that there are morphological and molecular similarities between FTC and the frequently occurring FA. Micro-RNAs (miRNAs) are a new class of small, noncoding RNAs implicated in development and cancer and may lend novel clues to FTC genesis. For the latter process, a deregulated miRNA can orchestrate the aberrant expression of several hundred target genes.
The objective of the study was to identify deregulated miRNAs in FTC.
We used two high-density expression arrays to identify miRNAs and their target genes that are differentially expressed between FTC and FA. Validation was done by quantitative RT-PCR. We further functionally characterized the effect of deregulated miRNAs in vitro using HEK293T, FTC133, and K5 cell lines.
In total, 45 primary thyroid samples (23 FTC, 20 FA, four normal control thyroid) were analyzed.
Two specific miRNAs, miR-197 and miR-346, were significantly overexpressed in FTC. In vitro overexpression of either miRNA induced proliferation, whereas inhibition led to growth arrest. Overexpression of miR-197 and miR-346 repressed the expression of their predicted target genes in vitro and in vivo.
Our observations show that miR-197 and miR-346 contribute to FTC carcinogenesis. Both miRNAs and their target genes might potentially provide for novel molecular markers and act as novel targets for treatment by interference, which could potentially normalize the deregulated profile of many downstream target genes.
尽管滤泡状甲状腺癌(FTC)的发病机制及其与滤泡性腺瘤(FA)的关系仍不清楚,但鉴于FTC与常见的FA在形态学和分子水平上存在相似性,深入了解FTC的致癌过程将有助于应对科学和临床挑战。微小RNA(miRNA)是一类新的小分子非编码RNA,与发育和癌症有关,可能为FTC的发生提供新线索。对于后一过程,失调的miRNA可协调数百个靶基因的异常表达。
本研究的目的是鉴定FTC中失调的miRNA。
我们使用两个高密度表达阵列来鉴定FTC和FA之间差异表达的miRNA及其靶基因。通过定量逆转录-聚合酶链反应进行验证。我们进一步在体外使用HEK293T、FTC133和K5细胞系对失调的miRNA的作用进行功能表征。
总共分析了45份原发性甲状腺样本(23份FTC、20份FA、4份正常对照甲状腺)。
两种特定的miRNA,即miR-197和miR-346,在FTC中显著过表达。任一miRNA的体外过表达均可诱导增殖,而抑制则导致生长停滞。miR-197和miR-346的过表达在体外和体内均抑制了其预测靶基因的表达。
我们的观察结果表明,miR-197和miR-346促成了FTC的致癌过程。这两种miRNA及其靶基因都可能提供新的分子标志物,并作为干扰治疗的新靶点,这可能会使许多下游靶基因的失调谱恢复正常。